Found: 112
Select item for more details and to access through your institution.
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of first‐line immune checkpoint inhibitor and anti‐angiogenic agent combination therapy for Kirsten rat sarcoma viral antigen‐mutant advanced non‐small‐cell lung cancer: a systematic review and network meta‐analysis
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 25, p. 1854, doi. 10.1111/1759-7714.15413
- By:
- Publication type:
- Article
Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 369, doi. 10.1111/1759-7714.15200
- By:
- Publication type:
- Article
An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 3, p. 248, doi. 10.1111/1759-7714.15191
- By:
- Publication type:
- Article
A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3232, doi. 10.1111/1759-7714.15115
- By:
- Publication type:
- Article
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2846, doi. 10.3390/cancers14122846
- By:
- Publication type:
- Article
Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-530
- By:
- Publication type:
- Article
Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 530, doi. 10.1186/1471-2407-14-530
- By:
- Publication type:
- Article
Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Gender Differences in Treatment Outcomes among Patients with Non-Small Cell Lung Cancer Given a Combination of Carboplatin and Paclitaxel.
- Published in:
- Oncology, 2008, v. 75, n. 3/4, p. 169, doi. 10.1159/000159268
- By:
- Publication type:
- Article
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 717, doi. 10.1038/mt.2015.10
- By:
- Publication type:
- Article
Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study.
- Published in:
- Oncologist, 2022, v. 27, n. 7, p. e554, doi. 10.1093/oncolo/oyab077
- By:
- Publication type:
- Article
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 156, doi. 10.1634/theoncologist.2015-0288
- By:
- Publication type:
- Article
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
- Published in:
- BMC Research Notes, 2015, v. 8, p. 1, doi. 10.1186/s13104-015-1762-z
- By:
- Publication type:
- Article
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 3, p. 259, doi. 10.1111/ajco.12485
- By:
- Publication type:
- Article
Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 5, p. 385, doi. 10.1016/j.cllc.2015.03.008
- By:
- Publication type:
- Article
Clinicopathological Features in Young Patients Treated for Small-Cell Lung Cancer: Significance of Immunohistological and Molecular Analyses.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 3, p. 244, doi. 10.1016/j.cllc.2013.06.012
- By:
- Publication type:
- Article
Perspectives of non-specialists on the potential to serve as ethics committee members.
- Published in:
- Journal of International Medical Research, 2019, v. 47, n. 5, p. 1868, doi. 10.1177/0300060518823941
- By:
- Publication type:
- Article
Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion.
- Published in:
- Internal Medicine, 2022, v. 61, n. 9, p. 1393, doi. 10.2169/internalmedicine.8195-21
- By:
- Publication type:
- Article
Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2022, v. 61, n. 8, p. 1211, doi. 10.2169/internalmedicine.7300-21
- By:
- Publication type:
- Article
Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan.
- Published in:
- Tohoku Journal of Experimental Medicine, 2007, v. 213, n. 1, p. 17, doi. 10.1620/tjem.213.17
- By:
- Publication type:
- Article
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 30, p. 3042, doi. 10.1111/1759-7714.15100
- By:
- Publication type:
- Article
Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2978, doi. 10.1111/1759-7714.14645
- By:
- Publication type:
- Article
Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 7, p. 1079, doi. 10.1111/1759-7714.14330
- By:
- Publication type:
- Article
A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 1, p. 129, doi. 10.1111/1759-7714.14243
- By:
- Publication type:
- Article
Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias.
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 5, p. 541
- By:
- Publication type:
- Article
Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up results.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 1, p. 56, doi. 10.3892/mco.2016.1076
- By:
- Publication type:
- Article
Research ethics consultation: an attempt and 5-year experience in a Japanese University Hospital.
- Published in:
- BMC Research Notes, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13104-018-3772-0
- By:
- Publication type:
- Article
A case of successful treatment with eltrombopag for severe immune-related thrombocytopenia induced by atezolizumab: Case report.
- Published in:
- Journal of Medical Investigation, 2023, v. 70, n. 3/4, p. 516, doi. 10.2152/jmi.70.516
- By:
- Publication type:
- Article
Academic investigators' interest in promoting specified clinical trials: Questionnaire survey before and after implementation of the Clinical Trial Act.
- Published in:
- Journal of Medical Investigation, 2021, v. 68, n. 1/2, p. 71, doi. 10.2152/jmi.68.71
- By:
- Publication type:
- Article
Phase I study of the second-generation, recombinant, human EGFR antibody necitumumab in Japanese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Combined therapy with anti-p-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in nk cell-depleted scid mice.
- Published in:
- International Journal of Cancer, 1999, v. 82, n. 1, p. 105, doi. 10.1002/(SICI)1097-0215(19990702)82:1<105::AID-IJC18>3.0.CO;2-C
- By:
- Publication type:
- Article
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 5, p. 773, doi. 10.1002/(SICI)1097-0215(19990301)80:5<773::AID-IJC23>3.0.CO;2-E
- By:
- Publication type:
- Article
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12451, doi. 10.1038/ncomms12451
- By:
- Publication type:
- Article
Clinical trends among patients with asthma hospitalized for COVID-19 based on data from a nationwide database: an observational study.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-02917-x
- By:
- Publication type:
- Article
A New Quinoline Derivative MS-209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P-glycoprotein-expressing Human Small Cell Lung Cancer Cells.
- Published in:
- Cancer Science, 2001, v. 92, n. 7, p. 785, doi. 10.1111/j.1349-7006.2001.tb01162.x
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF<sup>V600</sup> mutation-positive solid tumors: a phase 1 study.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 259, doi. 10.1007/s10637-017-0502-8
- By:
- Publication type:
- Article
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 207, doi. 10.1007/s10637-016-0411-2
- By:
- Publication type:
- Article
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 217, doi. 10.1007/s10637-017-0435-2
- By:
- Publication type:
- Article
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 66, doi. 10.1007/s10637-015-0300-0
- By:
- Publication type:
- Article
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 4, p. 881, doi. 10.1007/s10637-015-0243-5
- By:
- Publication type:
- Article
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 632, doi. 10.1007/s10637-015-0227-5
- By:
- Publication type:
- Article
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 641, doi. 10.1007/s10637-015-0229-3
- By:
- Publication type:
- Article